Basic Information
Sildenafil Teva
Regulatory Information
EMEA/H/C/001073
Authorised
November 30, 2009
September 24, 2009
17
July 4, 2022
Company Information
the netherlands
Teva B.V. Swensweg 5 2031 GA Haarlem
Teva Pharma B.V.
Drug Classification
Generic Medicine
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Sildenafil Teva to be effective, sexual stimulation is required.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Sildenafil Teva. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Sildenafil Teva.